BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 4,520,000 Value ($000) $4,454 Avg Close — Range —
Q4 2023
Shares 4,520,000 Value ($000) $4,466 Avg Close — Range —
Q3 2023
Shares 3,870,000 Value ($000) $3,764 Avg Close — Range —
Q2 2023
Shares 24,020,000 Value ($000) $23,654 Avg Close — Range —
Q1 2023
Shares 24,638,000 Value ($000) $25,340 Avg Close — Range —
Q4 2022
Shares 22,505,000 Value ($000) $23,941 Avg Close — Range —
Q3 2022
Shares 33,845,000 Value ($000) $33,619 Avg Close — Range —
Q2 2022
Shares 34,005,000 Value ($000) $33,750 Avg Close — Range —
Q1 2022
Shares 41,077,000 Value ($000) $41,277 Avg Close — Range —
Q4 2021
Shares 42,088,000 Value ($000) $44,271 Avg Close — Range —
Q3 2021
Shares 49,914,000 Value ($000) $51,336 Avg Close — Range —
Q2 2021
Shares 52,091,000 Value ($000) $54,278 Avg Close — Range —
Q1 2021
Shares 67,735,000 Value ($000) $69,432 Avg Close — Range —
Q4 2020
Shares 84,134,000 Value ($000) $90,539 Avg Close — Range —
Q3 2020
Shares 65,820,000 Value ($000) $68,775 Avg Close — Range —
Q2 2020
Shares 42,417,000 Value ($000) $52,220 Avg Close — Range —
Q1 2020
Shares 72,279,000 Value ($000) $75,347 Avg Close — Range —
Q4 2019
Shares 82,941,000 Value ($000) $88,038 Avg Close — Range —
Q3 2019
Shares 81,501,000 Value ($000) $80,309 Avg Close — Range —
Q2 2019
Shares 76,269,000 Value ($000) $79,350 Avg Close — Range —
Q1 2019
Shares 64,697,000 Value ($000) $66,562 Avg Close — Range —
Q4 2018
Shares 63,655,000 Value ($000) $63,475 Avg Close — Range —
Q3 2018
Shares 73,250,000 Value ($000) $77,604 Avg Close — Range —
Q2 2018
Shares 47,263,000 Value ($000) $48,018 Avg Close — Range —
Q1 2018
Shares 43,256,000 Value ($000) $40,793 Avg Close — Range —
Q4 2017
Shares 37,456,000 Value ($000) $37,478 Avg Close — Range —
Q3 2017
Shares 26,000,000 Value ($000) $26,383 Avg Close — Range —